Glen Eagle Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-175
| Closed | -$12.5K | – | 969 |
|
|
2021
Q4 | $12.5K | Sell |
175
-985
| -85% | -$70.1K | ﹤0.01% | 584 |
|
|
2021
Q3 | $86.8K | Hold |
1,160
| – | – | 0.03% | 291 |
|
|
2021
Q2 | $89.7K | Hold |
1,160
| – | – | 0.03% | 281 |
|
|
2021
Q1 | $85.6K | Hold |
1,160
| – | – | 0.03% | 270 |
|
|
2020
Q4 | $81.4K | Hold |
1,160
| – | – | 0.03% | 257 |
|
|
2020
Q3 | $65.7K | Hold |
1,160
| – | – | 0.03% | 271 |
|
|
2020
Q2 | $67.6K | Hold |
1,160
| – | – | 0.03% | 250 |
|
|
2020
Q1 | $53.9K | Hold |
1,160
| – | – | 0.04% | 253 |
|
|
2019
Q4 | $64.8K | Hold |
1,160
| – | – | 0.03% | 281 |
|
|
2019
Q3 | $54.9K | Hold |
1,160
| – | – | 0.04% | 273 |
|
|
2019
Q2 | $62.1K | Buy |
1,160
+100
| +9% | +$5.35K | 0.04% | 255 |
|
|
2019
Q1 | $58.5K | Buy |
1,060
+175
| +20% | +$9.66K | 0.04% | 254 |
|
|
2018
Q4 | $41.7K | Hold |
885
| – | – | 0.04% | 262 |
|
|
2018
Q3 | $52.6K | Hold |
885
| – | – | 0.04% | 254 |
|
|
2018
Q2 | $48.4K | Buy |
+885
| New | +$48.4K | 0.04% | 258 |
|